Novartis Pharmaceutical Manufacturing GmbH
Novartis Pharmaceutical Manufacturing GmbH is a drug establishment in Kundl, Austria, registered with the US FDA under FEI 3027031635. Its registered operations are: Analytical testing, API manufacture. 13 EU/UK GMP certificates are matched to this site, 4 inspected within the last three years.
Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology
Registered operations
Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.
GMP documents matched to this site (13)
| Document | Authority | Inspection | Source |
|---|---|---|---|
484296-105553013 GMP certificate | Competent authority of Austria | 4 Dec 2025 within 3-year review window | EudraGMDP |
484296-103675257 GMP certificate | Competent authority of Austria | 4 Dec 2025 within 3-year review window | EudraGMDP |
484296-105579653 GMP certificate | Competent authority of Austria | 4 Dec 2025 within 3-year review window | EudraGMDP |
484296-105654285 GMP certificate | Competent authority of Austria | 4 Dec 2025 within 3-year review window | EudraGMDP |
484296-102184789 GMP certificate | Competent authority of Austria | 15 Feb 2023 outside 3-year review window | EudraGMDP |
484296-101532805 GMP certificate | Competent authority of Austria | 15 Feb 2023 outside 3-year review window | EudraGMDP |
484296-104634283 GMP certificate | Competent authority of Austria | 15 Feb 2023 outside 3-year review window | EudraGMDP |
484296-102505016 GMP certificate | Competent authority of Austria | 15 Feb 2023 outside 3-year review window | EudraGMDP |
484296-104078701 GMP certificate | Competent authority of Austria | 15 Feb 2023 outside 3-year review window | EudraGMDP |
484296-103654468 GMP certificate | Competent authority of Austria | 15 Feb 2023 outside 3-year review window | EudraGMDP |
484296-103050828 GMP certificate | Competent authority of Austria | 15 Feb 2023 outside 3-year review window | EudraGMDP |
484296-104484913 GMP certificate | Competent authority of Austria | 15 Feb 2023 outside 3-year review window | EudraGMDP |
484296-104615153 GMP certificate | Competent authority of Austria | 15 Feb 2023 outside 3-year review window | EudraGMDP |
A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.
What this page does not show
- Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
- Capacity, scale, price or current availability: no regulator publishes these.
- FDA inspection classifications for this site, which are not yet linked.
Other sites registered by the same company
- Novartis d.o.o.Menges, Slovenia · API manufacture
- NOVARTIS FARMA SPATorre Annunziata, Italy
- Novartis Manufacturing LLCCarlsbad, United States · API manufacture
- Novartis Manufacturing LLCIndianapolis, United States · API manufacture
- Novartis Manufacturing LLCIndianapolis, United States · API manufacture
- Novartis Manufacturing NVPuurs-Sint-Amands, Belgium
- Novartis Pharma AGBasel, Switzerland · API manufacture
- Novartis Pharma Produktions GmbHWehr, Germany
- NOVARTIS PHARMA SASHuningue, France · API manufacture
- Novartis Pharma Schweizerhalle AGPratteln CH, Switzerland · API manufacture
- Novartis Pharma Stein AGStein, Switzerland · API manufacture
- Novartis Pharmaceutical Manufacturing GmbHLangkampfen, Austria · API manufacture